CME Group Inc. (NASDAQ:CME) Shares Bought by Aviso Wealth Management

Aviso Wealth Management grew its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 42.7% in the 3rd quarter, Holdings Channel reports. The fund owned 10,661 shares of the financial services provider’s stock after acquiring an additional 3,191 shares during the period. CME Group accounts for about 1.3% of Aviso Wealth Management’s investment portfolio, making the stock its 13th biggest position. Aviso Wealth Management’s holdings in CME Group were worth $2,352,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its stake in CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after acquiring an additional 45 shares during the period. CVA Family Office LLC boosted its stake in CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after acquiring an additional 46 shares during the period. Lester Murray Antman dba SimplyRich raised its holdings in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the last quarter. Zions Bancorporation N.A. raised its holdings in shares of CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after buying an additional 54 shares during the last quarter. Finally, Quent Capital LLC raised its holdings in shares of CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after buying an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 14.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of NASDAQ:CME opened at $225.28 on Monday. The firm has a market cap of $81.18 billion, a price-to-earnings ratio of 23.69, a P/E/G ratio of 5.20 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The business has a fifty day simple moving average of $222.62 and a 200 day simple moving average of $210.39.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company earned $2.25 EPS. The firm’s revenue was up 18.4% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CME. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price target on shares of CME Group in a report on Thursday, October 24th. Bank of America boosted their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Piper Sandler boosted their target price on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Finally, The Goldman Sachs Group boosted their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $224.47.

Read Our Latest Research Report on CME

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.